| |
|
|
|
Matinas Biopharma Hl
|
|
1.23 -0.04 (-3.15%) |
10/16/2017 4:00pm |
|
Open: |
N/A |
Pre close: |
1.27 |
Target:
|
1.58
|
|
High: |
N/A |
Low: |
N/A |
Resistance:
|
1.36
1.47
|
|
Volume: |
0 |
Market Cap: |
113.13M |
Support:
|
1.17
0.97
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.30
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.30 |
Signal(12,26,9): |
0.00 |
|
MA(100): |
1.62 |
Stochastic Oscillator |
%K(14,3):
|
23.08 |
|
MA(250): |
2.06 |
%D(3): |
41.39 |
|
Average Volume(K) |
3-Month: |
20557
|
52-Week |
High:
|
3.99 |
|
10-Days: |
14429 |
Low: |
1.01 |
|
RSI |
RSI(14):
|
39.30 |
Change(%): |
-30.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.210 |
Return on Equity (ttm) |
-134.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-68.8 |
Shares Float (M) |
69.98 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
27.92 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
10.76 |
|
Forward EPS |
-0.210 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
4760 |
|
Book Value (p.s.) |
0.020 |
EBITDA (p.s.) |
-0.138 |
P/E |
-5.86 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
61.50 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.24 |
P/S |
0.00 |
|
Operating Margin |
-21482.99 |
Levered Free Cash Flow
(M) |
-6.66 |
P/CF |
-0.00 |
|
|
|
|
|
|
|
